您当前的位置：
首页 >
文章列表页 >
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
更新时间：2026-01-27

    • The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report

    • China Oncology   Vol. 31, Issue 2, Pages: 156-160(2021)

    • DOI：10.19401/j.cnki.1007-3639.2021.02.011    

      CLC： R732.1

    • Published Online：02 March 2021，

      Published：02 March 2021

    移动端阅览

  • 李　磊, 王　智, 由春媛. The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report[J]. China Oncology, 2021, 31(2): 156-160. DOI： 10.19401/j.cnki.1007-3639.2021.02.011.

  •  
  •  
icon
试读结束，您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束，您可以通过登录账户，到个人中心，购买VIP会员阅读全文。
已是VIP会员？
去登录 >

0

Views

1836

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
Chinese expert consensus on whole-process management of chemotherapy-related diarrhea (2025 edition)
Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study
A prospective single-arm study of the efficacy and safety of lobaplatin-based HIPEC combined with optimal support in the treatment of abdominal metastatic cancer
A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer

Related Author

蔡树模
汤　洁
黄　啸
黄晓炜
刘素萍
柯桂好
郑　重
程　玺

Related Institution

复旦大学附属肿瘤医院妇瘤科，复旦大学上海医学院肿瘤学系
Department of Surgical Oncology, Minhang Branch, Fudan University Shanghai Cancer Center
Department of Pharmacy, Minhang Branch, Fudan University Shanghai Cancer Center
Department of Diagnostic Radiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Department of Gynecological Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
0